Iron protein succinylate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Iron protein succinylate
DrugBank Accession Number
DB11209
Background

Not Available

Type
Small Molecule
Groups
Approved, Investigational
Synonyms
Not Available
External IDs
  • ITF 282
  • ITF282

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Treatment ofAnemia of pregnancy••••••••••••••••••••
Treatment ofBlood loss anemia••••••••••••••••••••
Prevention ofIron deficiency••••••••••••••••••
Treatment ofIron deficiency••••••••••••••••••
Prevention ofIron deficiency anemia (ida)••••••••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
FERPLEX FOL 40 MG + 0.185 MG/15 ML ORAL ÇÖZELTİ, 10 ADETIron protein succinylate (40 mg) + Leucovorin calcium pentahydrate (0.185 mg)SolutionOralABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.2003-11-12Not applicableTurkey flag
KOMFER FOL 40 MG/185 MCG ORAL COZELTI, 10 FLK.Iron protein succinylate (800 mg) + Leucovorin calcium pentahydrate (0.235 mg)SolutionOralKOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş.2009-01-28Not applicableTurkey flag
KOMFER FOL 40 MG/185 MCG ORAL COZELTI, 20 FLK.Iron protein succinylate (800 mg) + Leucovorin calcium pentahydrate (0.235 mg)SolutionOralKOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş.2009-01-28Not applicableTurkey flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
OLIGOFER 40 MG ORAL COZELTI 10 FLAKONIron protein succinylate (40 mg)SolutionOralITF İLAÇ SAN. VE TİC. LTD. ŞTİ.2013-01-29Not applicableTurkey flag
PR Natal 400Iron protein succinylate (7.25 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (3000 [iU]/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (.012 mg/1) + DL-alpha tocopheryl acetate (30 mg/1) + Ferrous bisglycinate hydrochloride (21.75 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (374 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (4 mg/1) + Thiamine mononitrate (1.8 mg/1) + Zinc oxide (25 mg/1)KitOralPruGen, Inc Pharmaceuticals2010-01-01Not applicableUS flag
PR Natal 400 ecIron protein succinylate (7.25 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (3000 [iU]/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (.012 mg/1) + DL-alpha tocopheryl acetate (3 mg/1) + Ferrous bisglycinate hydrochloride (21.75 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (400 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (4 mg/1) + Thiamine mononitrate (1.8 mg/1) + Zinc oxide (25 mg/1)KitOralPruGen, Inc Pharmaceuticals2010-01-01Not applicableUS flag
PR Natal 430Iron protein succinylate (7.25 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (3000 [iU]/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (.012 mg/1) + DL-alpha tocopheryl acetate (30 mg/1) + Ferrous bisglycinate hydrochloride (21.75 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (430 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (4 mg/1) + Thiamine mononitrate (1.8 mg/1) + Zinc oxide (25 mg/1)KitOralPruGen, Inc Pharmaceuticals2010-01-01Not applicableUS flag
PR Natal 430 ecIron protein succinylate (7.25 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (3000 [iU]/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (.012 mg/1) + DL-alpha tocopheryl acetate (3 mg/1) + Ferrous bisglycinate hydrochloride (21.75 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (430 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (4 mg/1) + Thiamine mononitrate (1.8 mg/1) + Zinc oxide (25 mg/1)KitOralPruGen, Inc Pharmaceuticals2010-01-01Not applicableUS flag

Categories

ATC Codes
B03AB09 — Ferric proteinsuccinylate
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
VBJ9L90P4L
CAS number
250705-13-6
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
Not Available
RxNav
27823

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Unknown StatusTreatmentChronic Heart Failure (CHF) / Iron Deficiency (ID)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionOral40 mg/15ml
Granule, for solutionOral
SolutionOral60 mg
SolutionOral
SolutionOral
TabletOral
SolutionOral40 mg
SolutionOral60 mg/22.5ml
GranuleOral
KitOral
CapsuleOral
Capsule; kit; tablet, film coatedOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at December 03, 2015 16:51 / Updated at June 12, 2020 16:53